(Q38078826)

28 August 2017

1 reference

title

Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management (English)

1 reference

28 August 2017

Jan Fohlman

7

0 references

Tomas Bergström

object named as

Tomas Bergström

8

0 references

author name string

Marie Studahl

1

1 reference

28 August 2017

Lars Lindquist

2

1 reference

28 August 2017

Britt-Marie Eriksson

3

1 reference

28 August 2017

Göran Günther

4

1 reference

28 August 2017

Malin Bengner

5

1 reference

28 August 2017

Elisabeth Franzen-Röhl

6

1 reference

28 August 2017

Elisabeth Aurelius

9

1 reference

28 August 2017

publication date

1 February 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

73

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

131-158

1 reference

Viral encephalitis in England, 1989-1998: what did we miss?

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Etiology of aseptic meningitis and encephalitis in an adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

Tick-borne encephalitis

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Infectious encephalitis in france in 2007: a national prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

High diagnostic yield by CSF-PCR for entero- and herpes simplex viruses and TBEV serology in adults with acute aseptic meningitis in Stockholm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Dual infections of the central nervous system with Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Clinical characteristics of patients with Epstein Barr virus in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-term follow-up related to clinical course and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Polymerase chain reaction analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Screening for possible failure of herpes simplex virus PCR in cerebrospinal fluid for the diagnosis of herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex encephalitis. Clinical Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Long-term cognitive sequelae of acyclovir-treated herpes simplex encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Vidarabine versus acyclovir therapy in herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

HSV-1 and HSV-2 in herpes simplex encephalitis: a study of sixty-four cases in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Early diagnosis of herpes simplex encephalitis by MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex encephalitis with occipital localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Prevalence of nonconvulsive status epilepticus in comatose patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real-time PCR in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex encephalitis and management of acyclovir in encephalitis patients in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Primary and recurrent herpes simplex virus type 2-induced meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Clinical Spectrum and Laboratory Characteristics Associated With Detection of Herpes Simplex Virus DNA in Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes Simplex Virus Type 2 and Acute Aseptic Meningitis: Clinical Features of Cases with Isolation of Herpes Simplex Virus from Cerebrospinal Fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Genital herpes simplex virus infections: clinical manifestations, course, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Recurrent lymphocytic meningitis positive for herpes simplex virus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpes simplex virus type 2 in acute aseptic meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Recurrent lymphocytic meningitis: the role of herpesviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute central nervous system complications in varicella zoster virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

An increasing incidence of chickenpox central nervous system complications in children: what's happening in Tuscany?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neurologic varicella complications before routine immunization in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Course and outcome of acute cerebellar ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Stroke After varicella-zoster infection: report of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Fatal varicella-zoster virus antigen-positive giant cell arteritis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Bilateral middle cerebral artery infarctions following mild varicella infection: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Subcortical type cognitive impairment in herpes zoster encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Quantitative real time PCR detection of Varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Antiviral IgM and IgG subclasses in varicella zoster associated neurological syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

CSF and MRI findings in patients with acute herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpesvirus infections of the CNS: MR findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Cerebral vasculitis: imaging signs revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Clinical practice. Herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acyclovir improves recovery rate of facial nerve palsy in Ramsay Hunt syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella disease after introduction of varicella vaccine in the United States, 1995-2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Cytomegalovirus encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Infections of the central nervous system of suspected viral origin: a collaborative study from Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Detection of human herpesvirus-6 in cerebrospinal fluid of patients with encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neuroinvasion and persistence of human herpesvirus 6 in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Human herpesvirus-6 infection in children. A prospective study of complications and reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Human herpesvirus-6 infection in solid organ and stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The neuroanatomic localization of Epstein-Barr virus encephalitis may be a predictive factor for its clinical outcome: a case report and review of 100 cases in 28 reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Severe meningoencephalitis caused by human herpesvirus 6 type B in an immunocompetent woman treated with ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

MRI abnormalities in tick-borne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Magnetic resonance imaging findings and outcome in severe tick-borne encephalitis. Report of four cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Field effectiveness of vaccination against tick-borne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50-90 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Enteroviral infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996-2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Routine cerebrospinal fluid enterovirus polymerase chain reaction testing reduces hospitalization and antibiotic use for infants 90 days of age or younger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Cost analysis of enteroviral polymerase chain reaction in infants with fever and cerebrospinal fluid pleocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Impact of diagnostic procedures on patient management and hospitalization cost during the 2000 and 2005 enterovirus epidemics in Marseilles, France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Enteroviral meningitis: natural history and outcome of pleconaril therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Recent advances in the molecular epidemiology and control of human enterovirus 71 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute necrotizing encephalopathy in caucasian children: two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute necrotizing encephalopathy of childhood in non-Asian patients: report of three cases and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute necrotizing encephalopathy: a relapsing case in a European adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Childhood encephalitis in Sweden: etiology, clinical presentation and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neurological complications of pandemic influenza A H1N1 2009 infection: European case series and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Two newly proposed infectious encephalitis/encephalopathy syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Influenza virus and CNS manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute encephalopathy and encephalitis caused by influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Low penetration of oseltamivir and its carboxylate into cerebrospinal fluid in healthy Japanese and Caucasian volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Therapeutic brain concentration of the NMDA receptor antagonist amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute measles encephalitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Measles virus in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Subacute sclerosing panencephalitis: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Clinical appearance and outcome in mumps encephalitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Measles Infection of the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Measles virus infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Good cognitive outcome of patients with herpes zoster encephalitis: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Otological complications of herpes zoster

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Varicella-zoster virus: atypical presentations and unusual complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Herpesvirus infections of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Crystal-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Valacyclovir for herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Isolation and Characterization of Acyclovir-resistant Mutants of Herpes Simplex Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acyclovir resistance in herpes simplex encephalitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Neonatal herpes encephalitis caused by a virologically confirmed acyclovir-resistant herpes simplex virus 1 strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Compartmentalization of acyclovir-resistant varicella zoster virus: implications for sampling in molecular diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Persistent intrathecal immune activation in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Long-term outcome of patients presenting with acute infectious encephalitis of various causes in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

ENTEROVIRAL MENINGOENCEPHALITIS IN X-LINKED AGAMMAGLOBULINEMIA: INTENSIVE IMMUNOGLOBULIN THERAPY AND SEQUENTIAL VIRAL DETECTION IN CEREBROSPINAL FLUID BY POLYMERASE CHAIN REACTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Acute Viral Encephalitis in Adults?a Prospective Study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

21 January 2018

12 December 2020

Hematogenously Spread Herpesviruses Are Detected as Frequently as Neuronally Spread Herpesviruses in Cerebrospinal Fluid by Polymerase Chain Reaction Assay

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0007-5

Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients

21 January 2018

1 reference

12 December 2020

Vaccine failures after active immunisation against tick-borne encephalitis

1 reference

12 December 2020

Pharmacology and clinical use of foscarnet

1 reference

12 December 2020

Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis

1 reference

12 December 2020

Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient

1 reference

12 December 2020

Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. European Union Concerted Action on Virus Meningitis and Encephalitis.

1 reference

12 December 2020

Hypoglycorrhachia in herpes simplex type 2 meningitis

1 reference

12 December 2020

PCR for detection of rubella virus RNA in clinical samples.

1 reference

12 December 2020

Cytokine and Cellular Inflammatory Sequence in Enteroviral Meningitis

1 reference

12 December 2020

Combined therapy with hypothermia and anticytokine agents in influenza A encephalopathy

1 reference

12 December 2020

A retrospective analysis of forty-six cases of herpes simplex encephalitis seen in Glasgow between 1962 and 1985

1 reference

12 December 2020

Enterovirus 71: the virus, its infections and outbreaks

1 reference

12 December 2020

Herpes simplex virus resistance to acyclovir: clinical relevance.

1 reference

12 December 2020

Human herpesvirus 6 is associated with focal encephalitis

1 reference

12 December 2020

Acute encephalitis from 1967 to 1991

1 reference

12 December 2020

Epidemiology of tick-borne encephalitis in Sweden 1956-1989: a study of 1116 cases

1 reference

12 December 2020

Activity of pleconaril against enteroviruses

1 reference

12 December 2020

Accuracy of computed tomography in the diagnosis of herpes simplex encephalitis

1 reference

12 December 2020

Severe tick-borne encephalitis following passive immunization

1 reference

12 December 2020

Varicella zoster virus and central nervous system syndromes

1 reference

12 December 2020

Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid

1 reference

12 December 2020

Recurring episodes of meningitis (Mollaret's meningitis) with one showing an association with herpes simplex virus type 2.

1 reference

12 December 2020

Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group

1 reference

12 December 2020

Expanded spectrum of herpes simplex encephalitis in childhood

1 reference

12 December 2020

Severe complications of varicella in previously healthy children in Germany: a 1-year survey

1 reference

12 December 2020

Para-infectious encephalomyelitis and related syndromes; a critical review of the neurological complications of certain specific fevers.

1 reference

12 December 2020

Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis

1 reference

12 December 2020

Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults

1 reference

12 December 2020

Acute encephalitis complicating rubella

1 reference

12 December 2020

Insufficient protection for healthy elderly adults by tetanus and TBE vaccines

1 reference

12 December 2020

Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay

1 reference

12 December 2020

Quantitative PCR-enhanced immunoassay for measurement of enteroviral immunoglobulin M antibody and diagnosis of aseptic meningitis

1 reference

12 December 2020

Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system.

1 reference

12 December 2020

Subacute sclerosing panencephalitis

1 reference

12 December 2020

Recurrent strokes after varicella

1 reference

12 December 2020

Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant

1 reference

12 December 2020

The natural history of facial paralysis in herpes zoster

1 reference

12 December 2020

The long-term neuropsychological outcome of herpes simplex encephalitis in a series of unselected survivors

1 reference

12 December 2020

The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America

1 reference

12 December 2020

Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain

1 reference

12 December 2020

Intrathecal synthesis of antibodies to human herpesvirus 6 early antigen in patients with meningitis/encephalitis

1 reference

12 December 2020

Varicella as a risk factor for cerebral infarction in childhood: a case-control study

1 reference

12 December 2020

Vaccines for preventing influenza in healthy adults

1 reference

12 December 2020

SPECT and MR imaging in herpes simplex encephalitis

1 reference

12 December 2020

Clinical and radiological variability of influenza-related encephalopathy or encephalitis.

1 reference

12 December 2020

Population-based studies of varicella complications

1 reference

12 December 2020

Aseptic meningitis in association with herpes progenitalis

1 reference

12 December 2020

Early diagnosis of enteroviral meningitis by detection of specific IgM antibodies with a solid‐phase reverse immunosorbent test (SPRIST) and μ‐capture EIA

1 reference

12 December 2020

Cytomegalovirus infection of the central nervous system.

1 reference

12 December 2020

Long-term immunity after vaccination against tick-borne encephalitis with Encepur using the rapid vaccination schedule.

1 reference

12 December 2020

Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality

1 reference

12 December 2020

Coma as a presenting sign of Epstein-Barr encephalitis

1 reference

12 December 2020

Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir

1 reference

12 December 2020

Acute measles encephalitis in children with immunosuppression

1 reference

12 December 2020

Magnetic resonance imaging in a case of mumps postinfectious encephalitis with asymptomatic optic neuritis

1 reference

12 December 2020

Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults

1 reference

12 December 2020

Diagnosis of herpes simplex encephalitis. A comparison between electroencephalography and computed tomography findings.

1 reference

12 December 2020

Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.

1 reference

12 December 2020

Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis

1 reference

12 December 2020

Detection of enteroviral RNA by polymerase chain reaction in cerebrospinal fluid from patients with aseptic meningitis

1 reference

12 December 2020

Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster

1 reference

12 December 2020

The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-98: a prospective study of 656 patients

1 reference

12 December 2020

10.1007/S40265-013-0007-5

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1050144711

0 references

1 reference